Braveheart Bio, Inc. ยท NASDAQ:BRVE

Braveheart Bio, Inc. insider trades

Braveheart Bio, Inc.'s insiders made 13 buys and 0 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

DateInsiderTradeSharesPriceFiling
Aug 7, 2026Andreessen Marc LBuy1,100,000US$18Form 4
Aug 7, 2026Chimovits ErezBuy1,666,667US$18Form 4
Aug 7, 2026Chimovits ErezBuy273,333US$18Form 4
Aug 7, 2026OrbiMed Genesis GP LLCBuy1,666,667US$18Form 4
Aug 7, 2026OrbiMed Genesis GP LLCBuy273,333US$18Form 4
Aug 7, 2026Forbion Growth Opportunities Fund III Cooperatief U.A.Buy1,680,000US$18Form 4
Aug 7, 2026Forbion Growth Opportunities Fund III Cooperatief U.A.Buy1,920,000US$18Form 4
Aug 7, 2026Rickey James PaulBuy27,777US$18Form 4
Aug 7, 2026Viehbacher ChristopherBuy83,333US$18Form 4
Aug 7, 2026Malek David IBuy4,166US$18Form 4

Braveheart Bio, Inc. shareholders